\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ was\\ afebrile\\,\\ denied\\ fever\\ or\\ chills\\.\ \(0\)\
\-\ no\\ significant\\ abnormal\\ laboratory\\ values\\ were\\ obtained\\.\ \(0\)\
\-\ treatment\\ options\\ for\\ this\\ patient\\ include\\ percutaneous\\ radiofrequency\\ ablation\\,\\ surgical\\ excision\\ or\\ medical\\ management\\ in\\ hopes\\ of\\ spontaneous\\ regression\\.\\ each\\ of\\ the\\ above\\ have\\ pertinent\\ positive\\ and\\ negative\\ aspects\\ that\\ will\\ be\\ briefly\\ reviewed\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ currently\\,\\ a\\ percutaneous\\ ablation\\ is\\ the\\ preferred\\ method\\ for\\ treatment\\.\\ \\ percutaneous\\ ablation\\ can\\ be\\ ct\\-guided\\ allowing\\ for\\ a\\ method\\ that\\ is\\ more\\ precise\\,\\ has\\ a\\ high\\ success\\ rate\\,\\ less\\ invasive\\,\\ decreased\\ tissue\\ damage\\,\\ and\\ decreased\\ complications\\.\\ percutaneous\\ ablation\\ of\\ osteoid\\ osteomas\\ is\\ limited\\ when\\ the\\ lesion\\ is\\ juxtaposed\\ to\\ a\\ neurovascular\\ bundle\\ or\\ located\\ in\\ the\\ spine\\ close\\ to\\ the\\ spinal\\ cord\\.\\ surgery\\ may\\ be\\ the\\ preferred\\ method\\ in\\ spinal\\ lesions\\.\\ \ \(0\)\
\-\ concerns\\ with\\ percutaneous\\ ablation\\ is\\ a\\ limited\\ ability\\ to\\ confirm\\ the\\ histology\\ of\\ the\\ lesion\\.\\ ablation\\ is\\ typically\\ via\\ heat\\ and\\ this\\ has\\ a\\ limited\\ range\\ of\\ 10mm\\ spherically\\.\\ therefore\\,\\ ovoid\\ or\\ irregular\\ lesion\\ are\\ more\\ difficult\\ to\\ treat\\ \\(4\\)\\.\ \(0\)\
\-\ surgical\\ treatment\\ is\\ well\\-established\\ with\\ either\\ an\\ en\\-bloc\\ or\\ curettage\\ modality\\.\\ \\ it\\ has\\ a\\ high\\ success\\ rates\\,\\ confirmation\\ of\\ histopathology\\ is\\ possible\\.\\ as\\ stated\\ above\\,\\ surgery\\ for\\ spinal\\ lesions\\ may\\ be\\ preferred\\.\\ concerns\\ with\\ surgical\\ excision\\ is\\ wide\\ exposure\\ techniques\\,\\ more\\ invasive\\ leading\\ to\\ greater\\ tissue\\ damage\\,\\ and\\ delayed\\ recovery\\ \\(4\\)\\.\ \(0\)\
\-\ medical\\ management\\ is\\ based\\ on\\ the\\ inherent\\ nature\\ of\\ osteiod\\ osteoma\\ to\\ spontaneously\\ regress\\.\\ untoward\\ effects\\ of\\ medical\\ management\\ is\\ both\\ the\\ possibility\\ of\\ continuing\\ intense\\ pain\\ and\\ the\\ adverse\\ effects\\ of\\ medication\\ \\(4\\)\\.\ \(0\)\
\-\ after\\ unremarkable\\ radiographs\\ were\\ performed\\,\\ subsequent\\ ct\\ and\\ mri\\ of\\ the\\ femur\\ was\\ performed\\.\ \(0\)\
\-\ a\\ small\\ focal\\ radiolucent\\ lesion\\ found\\ in\\ the\\ distal\\ one\\ third\\ of\\ the\\ femur\\,\\ centered\\ in\\ the\\ cortex\\.\\ \\ subtle\\ reactive\\ sclerosis\\ can\\ be\\ seen\\ on\\ the\\ periphery\\ of\\ the\\ lesion\\.\\ the\\ radiolucency\\ is\\ no\\ greater\\ than\\ 1cm\\ at\\ its\\ longest\\ axis\\.\\ \\ subtle\\ central\\ calcification\\ is\\ present\\.\ \(0\)\
\-\ mild\\ surrounding\\ edema\\.\\ \\ no\\ medullary\\ extension\\.\ \(0\)\
\-\ osteoid\\ osteoma\ \(14\)\
\-\ \\â\\€\\¢\\ ostoid\\ osteoma\ \(0\)\
\-\ \\â\\€\\¢osteomyelitis\ \(0\)\
\-\ \\â\\€\\¢osteoblastoma\ \(0\)\
\-\ \\â\\€\\¢\\ brodie\\ abscess\ \(0\)\
\-\ \\â\\€\\¢\\ eosinophilic\\ granuloma\\/langerhans\\ cell\\ histiocytosis\ \(0\)\
\-\ this\\ 25\\ yo\\ man\\ who\\ presents\\ with\\ worsening\\ left\\ thigh\\ pain\\.\\ pain\\ awakens\\ patient\\ at\\ night\\ and\\ is\\ no\\ longer\\ relieved\\ by\\ naproxen\\.\ \(0\)\
\-\ based\\ on\\ the\\ patient\\ presentation\\,\\ osteoid\\ osteoma\\ was\\ high\\ on\\ the\\ differential\\ and\\ likely\\.\\ the\\ patient\\ was\\ a\\ 25\\ year\\ old\\ male\\.\\ patient\\ are\\ almost\\ exclusively\\ under\\ 30\\ years\\ old\\ and\\ male\\ to\\ female\\ ratio\\ is\\ 2\\-3\\:1\\.\\ he\\ had\\ typical\\ night\\ time\\ pain\\ symptoms\\ and\\ had\\ some\\ relief\\ from\\ naproxen\\.\ \(0\)\
\-\ appearance\\ on\\ imaging\\ is\\ also\\ typical\\ for\\ this\\ entity\\.\\ \\ imaging\\ showed\\ an\\ area\\ of\\ lucency\\ located\\ in\\ the\\ femur\\.\\ the\\ lower\\ extremity\\ is\\ a\\ common\\ location\\ for\\ osteoid\\ osteoma\\.\\ \\ the\\ most\\ common\\ location\\ is\\ in\\ the\\ femoral\\ neck\\ \\(3\\,4\\)\\.\\ \ \(0\)\
\-\ partial\\ relief\\ from\\ naproxen\\ is\\ expected\\.\\ while\\ salicylates\\ classically\\ are\\ described\\ to\\ ameliorate\\ pain\\ symptoms\\,\\ this\\ was\\ not\\ found\\ in\\ this\\ patient\\.\\ cox1\\ \\&\\ 2\\ over\\ expression\\ has\\ been\\ found\\ in\\ the\\ nidus\\ of\\ osteoid\\ osteomas\\ \\(3\\,4\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ablation\\:\\ 0\\.05977410638175164\ \(0\)\
\-\ osteoid\\:\\ 0\\.04952524080540054\ \(0\)\
\-\ osteoma\\:\\ 0\\.04727978403801797\ \(0\)\
\-\ percutaneous\\:\\ 0\\.04213276520314812\ \(0\)\
\-\ naproxen\\:\\ 0\\.03763171442618247\ \(0\)\
\-\ method\\:\\ 0\\.02971514448324032\ \(0\)\
\-\ preferred\\:\\ 0\\.02836787042281078\ \(0\)\
\-\ osteomas\\:\\ 0\\.0276693633625572\ \(0\)\
\-\ 3\\,4\\:\\ 0\\.024649139093595077\ \(0\)\
\-\ concerns\\:\\ 0\\.023279586839869502\ \(0\)\
\-\ femur\\:\\ 0\\.02062320918750413\ \(0\)\
\-\ limited\\:\\ 0\\.020145431682263\ \(0\)\
\-\ is\\:\\ 0\\.01989483200988787\ \(0\)\
\-\ success\\:\\ 0\\.019383987006786865\ \(0\)\
\-\ effects\\:\\ 0\\.018573098798798524\ \(0\)\
\-\ management\\:\\ 0\\.01801414214221029\ \(0\)\
\-\ spinal\\:\\ 0\\.017093721845696012\ \(0\)\
\-\ damage\\:\\ 0\\.017009397325575937\ \(0\)\
\-\ spherically\\:\\ 0\\.016416235426380817\ \(0\)\
\-\ en\\-bloc\\:\\ 0\\.016416235426380817\ \(0\)\
\-\ ostoid\\:\\ 0\\.016416235426380817\ \(0\)\
\-\ \\â\\€\\¢osteomyelitis\\:\\ 0\\.016416235426380817\ \(0\)\
\-\ \\â\\€\\¢osteoblastoma\\:\\ 0\\.016416235426380817\ \(0\)\
\-\ granuloma\\/langerhans\\:\\ 0\\.016416235426380817\ \(0\)\
\-\ awakens\\:\\ 0\\.016416235426380817\ \(0\)\
\-\ 2\\-3\\:1\\.\\:\\ 0\\.016416235426380817\ \(0\)\
\-\ cox1\\:\\ 0\\.016416235426380817\ \(0\)\
\-\ relief\\:\\ 0\\.01624272300824205\ \(0\)\
\-\ lesion\\:\\ 0\\.016206287020488406\ \(0\)\
\-\ invasive\\:\\ 0\\.015991545053696304\ \(0\)\
\-\ night\\:\\ 0\\.015463982606534196\ \(0\)\
\-\ well\\-established\\:\\ 0\\.015125458553829707\ \(0\)\
\-\ osteiod\\:\\ 0\\.015125458553829707\ \(0\)\
\-\ longest\\:\\ 0\\.015125458553829707\ \(0\)\
\-\ salicylates\\:\\ 0\\.015125458553829707\ \(0\)\
\-\ ameliorate\\:\\ 0\\.015125458553829707\ \(0\)\
\-\ found\\:\\ 0\\.015044835834928003\ \(0\)\
\-\ medical\\:\\ 0\\.014688881564614549\ \(0\)\
\-\ subtle\\:\\ 0\\.014618880058639644\ \(0\)\
\-\ juxtaposed\\:\\ 0\\.014370402486589178\ \(0\)\
\-\ untoward\\:\\ 0\\.014370402486589178\ \(0\)\
\-\ inherent\\:\\ 0\\.013419144341773553\ \(0\)\
\-\ 4\\:\\ 0\\.013301519023346621\ \(0\)\
\-\ located\\:\\ 0\\.013099445279025927\ \(0\)\
\-\ briefly\\:\\ 0\\.013079625614038068\ \(0\)\
\-\ bundle\\:\\ 0\\.013079625614038068\ \(0\)\
\-\ high\\:\\ 0\\.01306450313450735\ \(0\)\
\-\ excision\\:\\ 0\\.013062386318678933\ \(0\)\
\-\ 25\\:\\ 0\\.01286490226538947\ \(0\)\
\-\ radiofrequency\\:\\ 0\\.01279256661994634\ \(0\)\
\-\ typical\\:\\ 0\\.012761440201675968\ \(0\)\
\-\ hopes\\:\\ 0\\.012324569546797538\ \(0\)\
\-\ brodie\\:\\ 0\\.012324569546797538\ \(0\)\
\-\ be\\:\\ 0\\.012269615673593382\ \(0\)\
\-\ based\\:\\ 0\\.012136649393917917\ \(0\)\
\-\ ct\\-guided\\:\\ 0\\.012128367469222443\ \(0\)\
\-\ radiolucency\\:\\ 0\\.012128367469222443\ \(0\)\
\-\ expression\\:\\ 0\\.012128367469222443\ \(0\)\
\-\ greater\\:\\ 0\\.0119542508665568\ \(0\)\
\-\ has\\:\\ 0\\.011953072405916408\ \(0\)\
\-\ more\\:\\ 0\\.011939532454257912\ \(0\)\
\-\ precise\\:\\ 0\\.01178884874148696\ \(0\)\
\-\ above\\:\\ 0\\.011664576002338237\ \(0\)\
\-\ regress\\:\\ 0\\.011639793419934751\ \(0\)\
\-\ neurovascular\\:\\ 0\\.011501789747395231\ \(0\)\
\-\ 10mm\\:\\ 0\\.011501789747395231\ \(0\)\
\-\ adverse\\:\\ 0\\.011501789747395231\ \(0\)\
\-\ patient\\:\\ 0\\.01116600282386353\ \(0\)\
\-\ location\\:\\ 0\\.011101332167239825\ \(0\)\
\-\ exclusively\\:\\ 0\\.010837590596671335\ \(0\)\
\-\ this\\:\\ 0\\.010738963277252883\ \(0\)\
\-\ continuing\\:\\ 0\\.010660104228320637\ \(0\)\
\-\ reviewed\\:\\ 0\\.01057732627195037\ \(0\)\
\-\ regression\\:\\ 0\\.010349016547383643\ \(0\)\
\-\ nidus\\:\\ 0\\.010349016547383643\ \(0\)\
\-\ allowing\\:\\ 0\\.010278736607005902\ \(0\)\
\-\ surgical\\:\\ 0\\.01003475849302488\ \(0\)\
\-\ heat\\:\\ 0\\.009962351063625273\ \(0\)\
\-\ curettage\\:\\ 0\\.009905048161080107\ \(0\)\
\-\ 1cm\\:\\ 0\\.009905048161080107\ \(0\)\
\-\ radiolucent\\:\\ 0\\.009795475535339077\ \(0\)\
\-\ entity\\:\\ 0\\.009743015801695324\ \(0\)\
\-\ pain\\:\\ 0\\.00971702204404781\ \(0\)\
\-\ ability\\:\\ 0\\.009691993503393432\ \(0\)\
\-\ treatment\\:\\ 0\\.009662664578775905\ \(0\)\
\-\ confirmation\\:\\ 0\\.009546813724120227\ \(0\)\
\-\ techniques\\:\\ 0\\.009500831205329963\ \(0\)\
\-\ decreased\\:\\ 0\\.009462779898415492\ \(0\)\
\-\ histology\\:\\ 0\\.009455956807603593\ \(0\)\
\-\ relieved\\:\\ 0\\.009369327355769529\ \(0\)\
\-\ centered\\:\\ 0\\.009327478462190278\ \(0\)\
\-\ or\\:\\ 0\\.009325165260369717\ \(0\)\
\-\ classically\\:\\ 0\\.009286549399399262\ \(0\)\
\-\ rates\\:\\ 0\\.009246500600105102\ \(0\)\
\-\ was\\:\\ 0\\.009201839126756862\ \(0\)\
\-\ aspects\\:\\ 0\\.009168897813511864\ \(0\)\
\-\ treat\\:\\ 0\\.008987959734454792\ \(0\)\
\-\ spontaneously\\:\\ 0\\.008987959734454792\ \(0\)\
\-\ longer\\:\\ 0\\.008987959734454792\ \(0\)\
\-\ pertinent\\:\\ 0\\.008953790016264482\ \(0\)\
\-\ histopathology\\:\\ 0\\.00888727589596266\ \(0\)\
\-\ periphery\\:\\ 0\\.00888727589596266\ \(0\)\
\-\ performed\\:\\ 0\\.008873662313695787\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.008854889038026219\ \(0\)\
\-\ ratio\\:\\ 0\\.008823055828791022\ \(0\)\
\-\ ovoid\\:\\ 0\\.008760976833879306\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.008754270120647419\ \(0\)\
\-\ modality\\:\\ 0\\.008730696534304295\ \(0\)\
\-\ thigh\\:\\ 0\\.008700900740363065\ \(0\)\
\-\ stated\\:\\ 0\\.008671574191074163\ \(0\)\
\-\ recovery\\:\\ 0\\.008671574191074163\ \(0\)\
\-\ wide\\:\\ 0\\.00853149333215873\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.00853149333215873\ \(0\)\
\-\ lesions\\:\\ 0\\.008519778422137608\ \(0\)\
\-\ axis\\:\\ 0\\.008478284072486374\ \(0\)\
\-\ intense\\:\\ 0\\.008426553040629623\ \(0\)\
\-\ common\\:\\ 0\\.008328741943971684\ \(0\)\
\-\ exposure\\:\\ 0\\.008279461027000888\ \(0\)\
\-\ each\\:\\ 0\\.008232903667214263\ \(0\)\
\-\ for\\:\\ 0\\.008146459761371119\ \(0\)\
\-\ confirm\\:\\ 0\\.008099832970785687\ \(0\)\
\-\ \\,\\:\\ 0\\.008065849251911728\ \(0\)\
\-\ possibility\\:\\ 0\\.008036701589639168\ \(0\)\
\-\ medication\\:\\ 0\\.008016124613500276\ \(0\)\
\-\ chills\\:\\ 0\\.007955723727553994\ \(0\)\
\-\ values\\:\\ 0\\.007955723727553994\ \(0\)\
\-\ symptoms\\:\\ 0\\.007931685202600146\ \(0\)\
\-\ close\\:\\ 0\\.007767462802281426\ \(0\)\
\-\ denied\\:\\ 0\\.00774964259554744\ \(0\)\
\-\ expected\\:\\ 0\\.00774964259554744\ \(0\)\
\-\ options\\:\\ 0\\.007731991303267098\ \(0\)\
\-\ surgery\\:\\ 0\\.007728115695941434\ \(0\)\
\-\ almost\\:\\ 0\\.007697182861903684\ \(0\)\
\-\ medullary\\:\\ 0\\.007646160563601796\ \(0\)\
\-\ leading\\:\\ 0\\.007612906155035675\ \(0\)\
\-\ tissue\\:\\ 0\\.007543468113417481\ \(0\)\
\-\ nature\\:\\ 0\\.007532278956239913\ \(0\)\
\-\ reactive\\:\\ 0\\.007532278956239913\ \(0\)\
\-\ therefore\\:\\ 0\\.007516564117048359\ \(0\)\
\-\ imaging\\:\\ 0\\.007456513312683809\ \(0\)\
\-\ spontaneous\\:\\ 0\\.007424962172559026\ \(0\)\
\-\ a\\:\\ 0\\.007385471169806356\ \(0\)\
\-\ afebrile\\:\\ 0\\.007351925462776379\ \(0\)\
\-\ lucency\\:\\ 0\\.007309440029319822\ \(0\)\
\-\ were\\:\\ 0\\.007226392315418701\ \(0\)\
\-\ can\\:\\ 0\\.0072187052233484905\ \(0\)\
\-\ in\\:\\ 0\\.00706252341017187\ \(0\)\
\-\ may\\:\\ 0\\.006980738804089847\ \(0\)\
\-\ difficult\\:\\ 0\\.00696525997901801\ \(0\)\
\-\ under\\:\\ 0\\.006953657465515894\ \(0\)\
\-\ the\\:\\ 0\\.006951081353813588\ \(0\)\
\-\ either\\:\\ 0\\.0069306670822341454\ \(0\)\
\-\ had\\:\\ 0\\.00686722465266558\ \(0\)\
\-\ via\\:\\ 0\\.006830584631569917\ \(0\)\
\-\ cortex\\:\\ 0\\.006809056098234579\ \(0\)\
\-\ described\\:\\ 0\\.006777222888999384\ \(0\)\
\-\ on\\:\\ 0\\.00674013977993881\ \(0\)\
\-\ \\(\\:\\ 0\\.006725900616795722\ \(0\)\
\-\ \\)\\:\\ 0\\.006643740150030774\ \(0\)\
\-\ are\\:\\ 0\\.006507675265528501\ \(0\)\
\-\ delayed\\:\\ 0\\.006476685929730316\ \(0\)\
\-\ no\\:\\ 0\\.006409267416788097\ \(0\)\
\-\ range\\:\\ 0\\.006406405989352575\ \(0\)\
\-\ third\\:\\ 0\\.006380720100837984\ \(0\)\
\-\ partial\\:\\ 0\\.00636379091703677\ \(0\)\
\-\ to\\:\\ 0\\.006362280945146909\ \(0\)\
\-\ irregular\\:\\ 0\\.006347014250477429\ \(0\)\
\-\ currently\\:\\ 0\\.006305722150860442\ \(0\)\
\-\ complications\\:\\ 0\\.006305722150860442\ \(0\)\
\-\ worsening\\:\\ 0\\.006265325829424204\ \(0\)\
\-\ rate\\:\\ 0\\.006202460876118888\ \(0\)\
\-\ subsequent\\:\\ 0\\.006194749902811567\ \(0\)\
\-\ 30\\:\\ 0\\.006119346995260847\ \(0\)\
\-\ femoral\\:\\ 0\\.00605400003099405\ \(0\)\
\-\ cord\\:\\ 0\\.006046878808576166\ \(0\)\
\-\ its\\:\\ 0\\.006004714047403429\ \(0\)\
\-\ laboratory\\:\\ 0\\.005864230420584853\ \(0\)\
\-\ extremity\\:\\ 0\\.005819662885740108\ \(0\)\
\-\ calcification\\:\\ 0\\.005776137092098937\ \(0\)\
\-\ male\\:\\ 0\\.005754955448370477\ \(0\)\
\-\ sclerosis\\:\\ 0\\.005715670825747384\ \(0\)\
\-\ extension\\:\\ 0\\.005680311585068256\ \(0\)\
\-\ obtained\\:\\ 0\\.005657106332856317\ \(0\)\
\-\ typically\\:\\ 0\\.005617180203921736\ \(0\)\
\-\ \\&\\:\\ 0\\.005589176707898383\ \(0\)\
\-\ that\\:\\ 0\\.00549713492945558\ \(0\)\
\-\ presentation\\:\\ 0\\.00548119298787911\ \(0\)\
\-\ less\\:\\ 0\\.005389087531327155\ \(0\)\
\-\ fever\\:\\ 0\\.005384101725422656\ \(0\)\
\-\ possible\\:\\ 0\\.00535937098488654\ \(0\)\
\-\ unremarkable\\:\\ 0\\.00526828010927758\ \(0\)\
\-\ spine\\:\\ 0\\.005240416286788357\ \(0\)\
\-\ central\\:\\ 0\\.005235812582607\ \(0\)\
\-\ surrounding\\:\\ 0\\.005231220231591741\ \(0\)\
\-\ showed\\:\\ 0\\.00521751074101247\ \(0\)\
\-\ positive\\:\\ 0\\.005163660317102638\ \(0\)\
\-\ differential\\:\\ 0\\.005052066721327616\ \(0\)\
\-\ radiographs\\:\\ 0\\.005039610505031904\ \(0\)\
\-\ abscess\\:\\ 0\\.005031352409933458\ \(0\)\
\-\ area\\:\\ 0\\.005031352409933458\ \(0\)\
\-\ while\\:\\ 0\\.005006795604939131\ \(0\)\
\-\ will\\:\\ 0\\.004978549382456503\ \(0\)\
\-\ some\\:\\ 0\\.004832268629174598\ \(0\)\
\-\ yo\\:\\ 0\\.004788364102984659\ \(0\)\
\-\ negative\\:\\ 0\\.004752551510940175\ \(0\)\
\-\ from\\:\\ 0\\.004716706566682355\ \(0\)\
\-\ years\\:\\ 0\\.004672706027967379\ \(0\)\
\-\ neck\\:\\ 0\\.004672706027967379\ \(0\)\
\-\ when\\:\\ 0\\.004557413850309135\ \(0\)\
\-\ appearance\\:\\ 0\\.004551036455744211\ \(0\)\
\-\ focal\\:\\ 0\\.004544680827073374\ \(0\)\
\-\ abnormal\\:\\ 0\\.004538346816228885\ \(0\)\
\-\ edema\\:\\ 0\\.004500788620914881\ \(0\)\
\-\ time\\:\\ 0\\.00449460191292237\ \(0\)\
\-\ likely\\:\\ 0\\.004488435690755413\ \(0\)\
\-\ include\\:\\ 0\\.004463972975847834\ \(0\)\
\-\ he\\:\\ 0\\.004439827452575455\ \(0\)\
\-\ an\\:\\ 0\\.004400986459161005\ \(0\)\
\-\ been\\:\\ 0\\.004329226982242069\ \(0\)\
\-\ distal\\:\\ 0\\.0043264033313706275\ \(0\)\
\-\ one\\:\\ 0\\.004312348944712559\ \(0\)\
\-\ at\\:\\ 0\\.004311967049652265\ \(0\)\
\-\ cell\\:\\ 0\\.0042983998353472745\ \(0\)\
\-\ significant\\:\\ 0\\.004279044974030211\ \(0\)\
\-\ mild\\:\\ 0\\.004190416115328002\ \(0\)\
\-\ than\\:\\ 0\\.0041695509402574936\ \(0\)\
\-\ who\\:\\ 0\\.004148916963019929\ \(0\)\
\-\ both\\:\\ 0\\.004063687133493708\ \(0\)\
\-\ over\\:\\ 0\\.0040514759592922955\ \(0\)\
\-\ man\\:\\ 0\\.003763374009478583\ \(0\)\
\-\ most\\:\\ 0\\.003673808457594183\ \(0\)\
\-\ small\\:\\ 0\\.0036658757623484516\ \(0\)\
\-\ mri\\:\\ 0\\.003656007178611955\ \(0\)\
\-\ present\\:\\ 0\\.003594057269891398\ \(0\)\
\-\ lower\\:\\ 0\\.003578886535128236\ \(0\)\
\-\ it\\:\\ 0\\.003576998853878988\ \(0\)\
\-\ have\\:\\ 0\\.0034458809652981224\ \(0\)\
\-\ 2\\:\\ 0\\.0034266377961090244\ \(0\)\
\-\ and\\:\\ 0\\.0033521230117731556\ \(0\)\
\-\ after\\:\\ 0\\.0032923672301847346\ \(0\)\
\-\ female\\:\\ 0\\.0032714343974819993\ \(0\)\
\-\ old\\:\\ 0\\.0032586018505111904\ \(0\)\
\-\ of\\:\\ 0\\.0032542961116756542\ \(0\)\
\-\ presents\\:\\ 0\\.003250734256066901\ \(0\)\
\-\ seen\\:\\ 0\\.003144557942397933\ \(0\)\
\-\ also\\:\\ 0\\.0031370942154006543\ \(0\)\
\-\ by\\:\\ 0\\.0026496664864895246\ \(0\)\
\-\ as\\:\\ 0\\.0024070344616277987\ \(0\)\
\-\ \\.\\:\\ 0\\.0023798571685371803\ \(0\)\
\-\ not\\:\\ 0\\.0022994761112512764\ \(0\)\
\-\ ct\\:\\ 0\\.002225891347098776\ \(0\)\
\-\ left\\:\\ 0\\.0017804567398005862\ \(0\)\
\-\ year\\:\\ 0\\.0017804567398005862\ \(0\)\
\-\ with\\:\\ 0\\.0008715394867030892\ \(0\)\
